Daré Bioscience amends bylaws to update stockholder nomination procedures and other governance provisions

Dare Bioscience, Inc.

Bylaws amended effective Jan 24, 2023 to update advance notice procedures for director nominations and stockholder proposals.
Added requirement for stockholders to comply with Rule 14a-19; non-compliance renders nominees ineligible for election.
Prohibits nominating more candidates than board seats; requires stockholder or representative to appear at meeting.
Updated forum selection provision to require certain actions be brought in Delaware courts; stockholder consents to personal jurisdiction.
Other amendments to conform to Delaware law and make administrative, clarifying, and modernizing changes.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Dare Bioscience, Inc.: Amended and restated bylaws to update advance notice procedures, stockholder meeting provisions, officer duties, forum selection, and other conforming changes (effective 2023-01-24).

Change: bylaw amendment
Effective: 2023-01-24

Exact text from the filing

On January 24, 2023, the board of directors of Daré Bioscience, Inc. (the “Company”) amended and restated the Company’s amended and restated by-laws effective as of such date.

View on SEC.gov

13 governance changes filed in the last 30 days. Browse all governance changes →

Dare Bioscience, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-002809

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.